Announcement PDF ASX Announcement Investor Webinar Presentation Sydney Australia, 15 April 2025: Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q), (the Company or Recce), is pleased to announce a live online webinar. The webinar will be held online via Zoom at 2:00pm AEST on Tuesday, 22 April 2025. The webinar will be recorded for those who cannot attend. To attend the webinar, register using the link below: https://us02web.zoom.us/webinar/register/WN_KmQn9TeLQEmxR7c4ZQhORA During the webinar, Managing Director and Chief Executive Officer, Mr James Graham, Executive Chairman, Dr John Prendergast, and Chief Medical Adviser and Non-Executive Director, Dr Alan W Dunton will provide an update on recent clinical activities, the outlook for upcoming Phase 3 clinical trials and details of the recently announced AUD ~$15.8 million Placement and Entitlement Offer that will support the upcoming clinical activities as Recce progresses towards commercialisation in 2026. A copy of the presentation slides was released via the ASX and Company website on 10 April 2025. The slides can be accessed here. A full recording of the webinar will be made available via the Recce website following the event. This announcement has been approved for release by the Recce Pharmaceuticals Board.